Explore 3 Stock Ideas & Industry Insights Download Free Report

small-cap

Pets at Home Pounces Back – Investors Sniff Out Growth Ahead: PETS

Nov 13, 2025 | Team Kalkine
Pets at Home Pounces Back – Investors Sniff Out Growth Ahead: PETS
Image source: shutterstock

  • PETS:LSE
  • Investment Type
    Small-Cap
  • Risk Level
  • Action
  • Rec. Price (GBX)

Pets at Home Group PLC (LSE: PETS)

Pets at Home Group PLC (LSE: PETS) is an FTSE 250 listed, UK-based company operating in the pet care industry. It offers a range of products, services, and guidance for pets and their owners. Its offerings are accessible online and through around 450 pet care centers, many of which feature veterinary clinics and grooming salons. Additionally, the company runs a small animal veterinary network comprising roughly 440 general practices, located within its centers and at independent sites. This Report covers the Investment Highlights, Conclusion, and Recommendation on the stock.

The Company will announce FY26 interim results on 26 November 2025. 

Key Investment Rationale – Buy at GBX 206.20

  • Performance in the Vet Group Segment: The Vet Group continued to be a key driver of growth, recording a 7.1% increase in consumer revenue and a 7.8% rise in like-for-like sales. This solid performance was supported by higher average transaction values and a growing number of Care Plans, demonstrating the resilience and expanding appeal of the company’s veterinary services. Over the past three years, Vet Group consumer revenues have grown by around 40%, highlighting consistent and high-quality progress in this division.
  • Growing Customer Engagement and Subscription Momentum: Customer engagement showed steady improvement, with active Pets Club members increasing to 8.1 million and average consumer value rising by 1.2% year over year. Subscriptions were a standout performer, now accounting for 14.5% of total consumer revenue—up from 10.3% the previous year—representing a 40.8% jump. The introduction of initiatives like “Easy Repeat In Store” and “Pets Club Pricing” further strengthened loyalty and boosted recurring revenue streams.
  • Operational Progress and Strategic Resilience: Despite a subdued retail market, the company maintained decent cost control and protected gross margins while continuing to execute its productivity program for FY26. Key operational advancements included digital sales returning to double-digit growth, expansion in veterinary capacity with new openings and extensions, and progress toward a major insurance launch in 2026. The robust balance sheet and ongoing £25 million share buyback program underscore financial stability and management’s confidence in the long-term strategy.

PETS Daily Chart & Valuation

 PETS Daily Technical Chart, Source – Refinitiv

For conducting the valuation, the following peers have been considered: Card Factory PLC (LSE: CARD), Moonpig Group PLC (LSE: MOON), and others.

As per the above-mentioned price action and technical indicators analysis, a ‘Buy’ rating has been given on Pets at Home Group PLC (LSE: PETS) at the Current Market Price of GBX 206.20, as of November 13, 2025, at 10:54 AM GMT.

Markets are trading in a highly volatile zone currently due to certain Macro & Micro-economic data and prevailing geopolitical tensions. Therefore, it is prudent to follow a cautious approach while investing.

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is 13 November 2025. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Target Price refers to a price level which the stock is expected to reach as per the relative valuation method and/or technical analysis taking into consideration both short-term and long-term scenario.

Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the London Stock Exchange (LSE) and or REFINITIV. Typically, both sources (LSE and or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.’

Note 6: Dividend Yield may vary as per the stock price movement.


Disclaimer-

This report has been issued by Kalkine Limited (Company number 07903332), a private limited company, incorporated in England and Wales ("Kalkine”). Kalkine.co.uk and associated pages are published by Kalkine. Kalkine is authorised and regulated by the Financial Conduct Authority under reference number 579414.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites.  All information represents our views at the date of publication and may change without notice. The information in this report does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products. Our reports contain non personalized recommendations to invest in securities and other financial products.

Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall not be held liable for any investment or trading losses you may incur by using the opinions expressed in our reports, publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.

Please also read our Terms & Conditions for further information. Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this report or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Kalkine Media Limited, an affiliate of Kalkine, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website including entities covered in this report.

Past performance is not a reliable indicator of future performance.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions